Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Interest & Investment Income (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Interest & Investment Income for 2 consecutive years, with $590000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 578.16% to $590000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, up 42.98% year-over-year, with the annual reading at $3.6 million for FY2025, 287.1% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $590000.0 at Pyxis Oncology, down from $800000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $1.8 million in Q3 2024, with the low at $87000.0 in Q4 2024.